Treatment of Acute HIV Infection to Preserve Immune Function
Immune Control of HIV Replication
2 other identifiers
observational
500
1 country
1
Brief Summary
While most people with HIV experience significant destruction of their immune systems, some people appear to have preserved immune function and can control the virus without drugs. Early treatment with anti-HIV drugs may help preserve the immune system, allowing it to control the virus once the drugs are stopped. This study will evaluate the immune system response of HIV infected people who are treated with anti-HIV drugs soon after being infected.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 1999
CompletedFirst Submitted
Initial submission to the registry
February 19, 2003
CompletedFirst Posted
Study publicly available on registry
February 20, 2003
CompletedJune 24, 2005
April 1, 2004
February 19, 2003
June 23, 2005
Conditions
Keywords
Eligibility Criteria
You may qualify if:
- Acute HIV infection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Massachusetts General Hospital
Boston, Massachusetts, 02116, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Bruce Walker, MD
Massachusetts General Hospital
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- NIH
Study Record Dates
First Submitted
February 19, 2003
First Posted
February 20, 2003
Study Start
July 1, 1999
Last Updated
June 24, 2005
Record last verified: 2004-04